BioSpace News Archive

Business

2022-23 AAOMS officers and trustees announced

Paul J. Schwartz, DMD, was introduced as the 2022-23 President of the American Association of Oral and Maxillofacial Surgeons during its recent Annual Meeting in New Orleans, La.

October 17, 2022
·
4 min read
Inversago Pharma Raises $95 million CAD in Series C Financing

Inversago Pharma Inc., a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, announced the completion of a Series C funding of $95 million CAD, led by New Enterprise Associates.

October 17, 2022
·
4 min read
Drug Development

Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia

Milestone Pharmaceuticals Inc. announced positive topline efficacy and safety data from the Phase 3 RAPID clinical trial of etripamil, the Company’s investigational calcium channel blocker, in patients with paroxysmal supraventricular tachycardia.

October 17, 2022
·
9 min read
Pharm Country

New, peer reviewed study shows novel DermiSphere™ hydrogel enhances skin grafts

FesariusTherapeutics, Inc., an emerging bioregenerative technology company, announced the first publication describing its proprietary DermiSphere™ differential density collagen platform technology for advanced dermal regeneration.

October 17, 2022
·
2 min read
Genetown

Moderna Announces Update to 2022 Supply Agreement with Gavi that Secures Access to Updated Variant-Specific COVID-19 Vaccines for Low-and-Middle Income Countries

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Gavi, the Vaccine Alliance, have mutually agreed to cancel remaining pending orders under the current COVID-19 vaccine supply agreement for 2022.

October 17, 2022
·
4 min read
Genetown

Apnimed Announces Positive Topline Results for MARIPOSA Trial of AD109, Drug Candidate with the Potential to be the First Oral Therapy for Obstructive Sleep Apnea (OSA)

Apnimed announced positive topline results from the MARIPOSA Phase 2b trial, an efficacy, safety and dose-finding study of one-month duration.

October 17, 2022
·
7 min read
Business

KalVista Pharmaceuticals Announces Appointment of Brian J.G. Pereira, M.D. as Board Chairman

KalVista Pharmaceuticals, Inc. announced that the Board of Directors has appointed current member Brian J.G. Pereira, M.D., as Chairman, effective immediately.

October 17, 2022
·
4 min read
Business

Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts

Replay today announced that it has established a scientific advisory board (SAB) comprising ten experts across a broad range of areas of scientific importance in genomic medicine and cell therapy.

October 17, 2022
·
6 min read
Drug Development

Attralus Announces First Subject Enrolled in Phase 1 Clinical Trial of AT-02, Its Lead Pan-Amyloid Removal Therapeutic Candidate

Attralus, Inc. today announced that the first subject has been dosed in the Phase 1 clinical trial of AT-02, the company’s lead pan-amyloid removal (PAR) therapeutic.

October 17, 2022
·
4 min read
Business

Zentalis Pharmaceuticals Appoints Dr. Mark Lackner as Chief Translational Officer, Head of Biomarker Strategy

Zentalis™ Pharmaceuticals, Inc. today announced the appointment of Mark Lackner, PhD, as Chief Translational Officer, Head of Biomarker Strategy.

October 17, 2022
·
6 min read